Inventor · disambiguated record
Chantal Combredet
Also filed as: COMBREDET CHANTAL
15 granted patents·2 pending applications·113 citations·filing 2004–2021
93Inventor score
Top patents by PatentIndex Score
17 records- 0191US8337857B2Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infectionTANGY FREDERIC·Filed 2006·Granted Dec 25, 2012·11 cites·21 claims
- 0291US7556812B2Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applicationsPASTEUR INSTITUT·Filed 2005·Granted Jul 7, 2009·14 cites·5 claims
- 0390US8343718B2Strain of SARS-associated coronavirus and applications thereofPASTEUR INSTITUT·Filed 2010·Granted Jan 1, 2013·22 cites·8 claims
- 0489US9701944B2Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositionsTANGY FREDERIC·Filed 2015·Granted Jul 11, 2017·5 cites·14 claims
- 0589US8853379B2Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infectionTANGY FREDERIC·Filed 2011·Granted Oct 7, 2014·9 cites·15 claims
- 0688US8859240B2Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applicationsTANGY FRÉDÉRIC·Filed 2009·Granted Oct 14, 2014·7 cites·14 claims
- 0787US9005925B2Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositionsTANGY FRÉDÉRIC·Filed 2008·Granted Apr 14, 2015·12 cites·13 claims
- 0881US7736850B2Strain of SARS-associated coronavirus and applications thereofPASTEUR INSTITUT·Filed 2004·Granted Jun 15, 2010·18 cites·5 claims
- 0978US11020473B2Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseasesPASTEUR INSTITUT·Filed 2017·Granted Jun 1, 2021·2 cites·19 claims
- 1076US9005961B2Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositionsTANGY FRÉDERIC·Filed 2004·Granted Apr 14, 2015·10 cites·11 claims
- 1173US10314905B2Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapyPASTEUR INSTITUT·Filed 2018·Granted Jun 11, 2019·1 cites·6 claims
- 1273US9889193B2Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapyPASTEUR INSTITUT·Filed 2014·Granted Feb 13, 2018·2 cites·6 claims
- 1369US10980873B2Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapyPASTEUR INSTITUT·Filed 2019·Granted Apr 20, 2021·0 cites·10 claims
- 1466US9579375B2Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infectionPASTEUR INSTITUT·Filed 2014·Granted Feb 28, 2017·0 cites·12 claims
- 1564US10227385B2Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infectionPASTEUR INSTITUT·Filed 2017·Granted Mar 12, 2019·0 cites·12 claims
- 1656US2023235356A1An improved measles virus vaccine vector based on multiple tandem additional transcription units (atus)PASTEUR INSTITUT·Filed 2021·Application pending·0 cites
- 1746US2012082693A1Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strainVAN DER WERF SYLVIE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chantal Combredet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →